Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-22T07:43:16.109Z Has data issue: false hasContentIssue false
  • English
  • Français

Measurement of agitation and aggression in adult and aged neuropsychiatric patients: review of definitions and frequently used measurement scales

Published online by Cambridge University Press:  09 February 2017

Ladislav Volicer ,
Leslie Citrome  and
Jan Volavka
Ladislav Volicer*
Affiliation:
School of Aging Studies, University of South Florida, Tampa, Florida, USA
Leslie Citrome
Affiliation:
New York Medical College, Department of Psychiatry and Behavioral Sciences, Valhalla, New York, USA
Jan Volavka
Affiliation:
New York University School of Medicine, Department of Psychiatry, New York, New York, USA
*
*Address correspondence and reprint requests to: Ladislav Volicer, School of Aging Studies, University of South Florida, 4202 East Fowler Avenue, Tampa, Florida 33620, USA. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Agitation and aggression in adult psychiatric patients with psychoses and in persons with dementia increase the burden of disease and frequently cause hospitalization. The implementation of currently available management strategies and the development of new ones is hindered by inconsistent terminology that confuses agitation with aggression. This confusion is maintained by many rating scales that fail to distinguish between these two syndromes. We review the frequently used rating scales with a particular focus on their ability to separate agitation from aggression. Agitation and aggression are two different syndromes. For example, reactive aggression is often precipitated by rejection of care and may not be associated with agitation per se. We propose, in treatment studies of behavioral symptoms of dementia and challenging behaviors in psychoses, that outcomes should be evaluated separately for agitation and aggression. This is important for investigation of drug effectiveness since the medication may be effective against one syndrome but not the other. Separate assessments of agitation and aggression should be a general principle of trial design with particular salience for registration studies of medications proposed for approval by the U.S. Food and Drug Administration and other regulatory bodies.

Keywords

Agitationaggressionpsychosisdementia
Type
Review Articles
Information
CNS Spectrums , Volume 22 , Issue 5 , October 2017 , pp. 407 - 414
Copyright
© Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Phillips, VL, Diwan, S. The incremental effect of dementia-related problem behaviors on the time to nursing home placement in poor, frail, demented older people. J Am Geriatr Soc. 2003; 51: 188–193.Google Scholar
2. Cummings, J, Mintzer, J, Brodaty, H, et al. Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition. Int Psychogeriatr. 2015; 27(1): 7–17. Epub ahead of print Oct 14, 2014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301197/. Accessed January 17, 2017.Google Scholar
3. Merriam Webster Dictionary. http://www.merriam-webster.com/medical/agitation. Accessed January 17, 2017.Google Scholar
4. Lindenmayer, JP. The pathophysiology of agitation. J Clin Psychiatry. 2000; 61(Suppl. 14): 5–10.Google ScholarPubMed
5. Citrome, L, Volavka, J. Treatment of violent behavior. In: Tasman A, Kay J, Lieberman JA, eds. Psychiatry, 2nd ed. Chichester: John Wiley & Sons; 2003: P. 2136–2146.Google Scholar
6. Hurley, AC, Volicer, L, Camberg, L, et al. Measurement of observed agitation in patients with Alzheimer’s disease. J Mental Health Aging. 1999; 5: 117–133.Google Scholar
7. Volavka, J. Neurobiology of Violence, 2nd ed. Washington, DC: American Psychiatric Publishing; 2002.Google Scholar
8. Gardner, KJ, Archer, J, Jackson, S. Does maladaptive coping mediate the relationship between borderline personality traits and reactive and proactive aggression? Aggress Behav. 2012; 38(5): 403–413. Epub ahead of print Jun 18.Google Scholar
9. Miller, JD, Lynam, DR. Reactive and proactive aggression: similarities and differences. Pers Individ Dif. 2006; 41: 1469–1480. https://pdfs.semanticscholar.org/b2af/27e3df2930e8566b8f4cce7d29d852d10e89.pdf. Accessed January 17, 2017.Google Scholar
10. Nolan, KA, Czobor, P, Roy, BB, et al. Characteristics of assaultive behavior among psychiatric inpatients. Psychiatr Serv. 2003; 54(7): 1012–1016. http://ps.psychiatryonline.org/doi/pdf/10.1176/appi.ps.54.7.1012. Accessed January 17, 2017.Google Scholar
11. Ryden, MB, Bossenmaier, M, McLachlan, C. Aggressive behavior in cognitively impaired nursing home residents. Res Nurs Health. 1991; 14(2): 87–95.CrossRefGoogle ScholarPubMed
12. Mahoney, EK, Hurley, AC, Volicer, L, et al. Development and testing of the Resistiveness to Care Scale. Res Nurs Health. 1999; 22(1): 27–38.Google Scholar
13. van der Linde, RM, Blossom, CM, Dening, T, Brayne, C. Instruments to measure behavioural and psychological symptoms of dementia. Int J Methods Psychiatr Res. 2014; 23(1): 69–98. Epub ahead of print Feb 5.Google Scholar
14. National Institute of Mental Health. CGI: Clinical Global Impressions. In: Guy W, ed. Manual for the ECDEU Assessment Battery. Chevy Chase, MD: National Institute of Mental Health; 1970: P. 12–16.Google Scholar
15. Meehan, K, Zhang, F, David, S, et al. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. Clin Psychopharmacol. 2001; 21(4): 389–397.Google Scholar
16. Swift, RH, Harrigan, EP, Cappelleri, JC, Kramer, D, Chandler, LP. Validation of the behavioural activity rating scale (BARS): a novel measure of activity in agitated patients. J Psychiatr Res. 2002; 36(2): 87–95.Google Scholar
17. Volavka, J, Swanson, JW, Citrome, LL. Understanding and managing violence in schizophrenia. In: Lieberman JA, Murray RM, eds. Comprehensive Care of Schizophrenia: A Textbook of Clinical Management, 2nd ed. New York: Oxford University Press; 2012: P. 262–290.Google Scholar
18. Lieberman, JA, Stroup, TS, McEvoy, JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005; 353(12): 1209–1223. Epub ahead of print Sep 19. http://www.nejm.org/doi/pdf/10.1056/NEJMoa051688. Accessed January 17, 2017.Google Scholar
19. Steadman, HJ, Mulvey, EP, Monahan, J, et al. Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods. Arch Gen Psychiatry. 1998; 55(5): 393–401. http://jamanetwork.com/journals/jamapsychiatry/fullarticle/203874. Accessed January 17, 2017.Google Scholar
20. Swanson, JW, Swartz, MS, Van Dorn, RA, et al. A national study of violent behavior in persons with schizophrenia. Arch Gen Psychiatry. 2006; 63(5): 490–499. http://jamanetwork.com/journals/jamapsychiatry/fullarticle/209569. Accessed January 17, 2017.Google Scholar
21. Citrome, L, Volavka, J, Czobor, P, et al. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. Psychiatr Serv. 2001; 52(11): 1510–1514. http://ps.psychiatryonline.org/doi/pdf/10.1176/appi.ps.52.11.1510. Accessed January 17, 2017.CrossRefGoogle ScholarPubMed
22. Volavka, J, Czobor, P, Nolan, K, et al. Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychopharmacol. 2004; 24(2): 225–228.Google Scholar
23. Kay, SR, Sevy, S. Pyramidical model of schizophrenia. Schizophr Bull. 1990; 16(3): 537–545.Google Scholar
24. Montoya, A, Valladares, A, Lizan, L, San, L, Escobar, R, Paz, S. Validation of the excited component of the Positive and Negative Syndrome Scale (PANSS–EC) in a naturalistic sample of 278 patients with acute psychosis and agitation in a psychiatric emergency room. Health Qual Life Outcomes. 2011; 9: 18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078838/. Accessed January 17, 2017.Google Scholar
25. Huber, CG, Hochstrasser, L, Meister, K, Schimmelmann, BG, Lambert, M. Evidence for an agitated-aggressive syndrome in early-onset psychosis correlated with antisocial personality disorder, forensic history, and substance use disorder. Schizophr Res. 2016; 175(1–3): 198–203. Epub ahead of print Apr 23.Google Scholar
26. Cohen–Mansfield, J, Marx, MS, Rosenthal, AS. A description of agitation in a nursing home. J Gerontol. 1989; 44(3): M77–M84.Google Scholar
27. Koss, E, Weiner, M, Ernesto, C. Assessing patterns of agitation in Alzheimer’s disease patients with the Cohen–Mansfield Agitation Inventory. The Alzheimer’s Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997; 11(Suppl. 2): S45–S50.Google Scholar
28. Cohen–Mansfield, J. Instruction Manual for the Cohen–Mansfield Agitation Inventory (CMAI). Rockville, MD: Cohen–Mansfield; 1991. https://shine-dementia.wikispaces.com/file/view/Cohen–Mansfield+Agitation+Inventory+(CMAI).pdf, Accessed January 17, 2017.Google Scholar
29. Cummings, JL, Mega, M, Gray, K, Rosenberg-Thompson, S, Carusi, DA, Gornbein, J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994; 44(12): 2308–2314.Google Scholar
30. Neuropsychiatric Inventory: Setting the Standard for Alzheimer Research (NPI). http://npitest.net/about-npi.html. Accessed January 17, 2017.Google Scholar
31. Aalten, P, Verhey, FR, Boziki, M, et al. Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium, part II. Dementia Geriatr Cogn Disord. 2008; 25(1): 1–8. Epub ahead of print Nov 15, 2007.Google Scholar
32. Nagata, M, Shinagawa, S, Nakajima, S, et al. Classification of neuropsychiatric symptoms requiring antipsychotic treatment in patients with Alzheimer’s disease: analysis of the CATIE–AD Study. J Alzheimers Dis. 2016; 50(3): 839–845.Google Scholar
33. Volicer, L, Hurley, A. Agitation in dementia. In: Assessment Scales for Advanced Dementia. London: Health Profession Press; 2015: P. 149–184.Google Scholar
34. Williams, KN, Hermann, B, Gajweski, B, Wilson, K. Elderspeak communication: impact on dementia care. Am J Alzheimers Dis Other Demen. 2009; 24(1): 11–20. Epub ahead of print Jun 30, 2008. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823803/. Accessed January 17, 2017.Google Scholar
35. Hammar, LM, Emami, A, Gottel, E, Engstrom, G. The impact of caregivers’ singing on expressions of emotion and resistance during morning care situations in persons with dementia: an intervention in dementia care. J Clin Nurs. 2011; 20(7–8): 969–978. Epub ahead of print Feb 10.Google Scholar
36. Volicer, L, Hurley, A. Rejection of care in dementia. Assessment Scales for Advanced Dementia. London: Health Professions Press; 2015. P. 185–214.Google Scholar
37. Brown, GL, Goodwin, FK, Ballenger, JC, Goyer, PF, Major, LF. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979; 1(2): 131–139.Google Scholar
38. Coccaro, EF, Berman, ME, Kavoussi, RJ. Assessment of life history of aggression: development and psychometric characteristics. Psychiatry Res. 1997; 73(3): 147–157.Google Scholar
39. Citrome, L. Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. J Clin Psychiatry. 2007; 68(12): 1876–1885.Google Scholar
40. Citrome, L. Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents. Ther Clin Risk Manag. 2013; 9: 235–245. Epub ahead of print May 20. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665578/Accessed January 17, 2017.Google Scholar
41. Citrome, L, Volavka, J. Preventing violence in patients with schizophrenia. Curr Treat Options Psychiatry. 2015; 2: 182–191.Google Scholar
42. Volicer, L, Bass, EA, Luther, SL. Agitation and resistiveness to care are two separate behavioral syndromes of dementia. J Am Med Dir Assoc. 2007; 8(8): 527–532.Google Scholar
43. Volicer, L, Frijters, DH, van der Steen, JT. Relationship between symptoms of depression and agitation in nursing home residents with dementia. Int J Geriatr Psychiatry. 2012; 27(7): 749–754. Epub ahead of print Sep 28, 2001.Google Scholar
44. Galindo-Garre, F, Volicer, L, van der Steen, JT. Factors related to rejection of care and behaviors directed towards others: a longitudinal study in nursing home residents with dementia. Dement Geriatr Cogn Dis Extra. 2015; 5(1): 123–134. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439779/. Accessed January 17, 2017.Google Scholar
45. Harris, GT, Varney, GW. A ten-year study of assaults and assaulters on a maximum security psychiatric unit. J Interpers Violence. 1986; 1: 173–191.Google Scholar
46. Volicer, L. What is NPI item “agitation/aggression” really measuring? Am J Geriatr Psychiatry. 2011; 19(12): 1046–1047.CrossRefGoogle ScholarPubMed
47. Cohen–Mansfield, J, Marx, MS, Dakheel-Ali, M, Regier, NG, Thein, K, Freedman, L. Can agitated behavior of nursing home residents with dementia be prevented with the use of standardized stimuli? J Am Geriatr Soc. 2010; 58(8): 1459–1464. Epub ahead of print Jun 23. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955178/Accessed January 17, 2017.Google Scholar
48. Sloane, PD, Honn, VJ, Dwyer, SAR, Wieselquist, J, Cain, C, Meyers, S. Bathing the Alzheimer’s patient in long term care: results and recommendations from three studies. Am J Alzheimers Dis Other Demen. 1995; 70(4): 3–12. http://journals.sagepub.com/doi/abs/10.1177/153331759501000403. Accessed January 17, 2017.Google Scholar
49. Volavka, J, Citrome, L. Heterogeneity of violence in schizophrenia and implications for long-term treatment. Int J Clin Pract. 2008; 62(8): 1237–1241. Epub ahead of print Jun 28.Google Scholar
50. Ballard, C, Corbett, A. Agitation and aggression in people with Alzheimer’s disease. Curr Opin Psychiatry. 2013; 26(3): 252–259.Google Scholar
51. Garay, RP, Citrome, L, Grossberg, GT, Cavero, I, Llorca, PM. Investigational drugs for treating agitation in persons with dementia. Expert Opin Investig Drugs. 2016; 25(8): 973–983. Epub ahead of print Jun 7.Google Scholar
52. Soto, M, Abushakra, S, Cummings, J, et al. Progress in treatment development for neuropsychiatric symptoms in Alzheimer’s disease: focus on agitation and aggression. A report from the EU/US/CTAD Task Force. J Prev Alzheimers Dis. 2015; 2(3): 184–188. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580980/Accessed January 17, 2017.Google Scholar
53. Siem, C, Rantz, M. Operationalizing the MDS 3.0 in the nursing home. J Am Med Dir Assoc. 2013; 14(8): 445–446. Epub ahead of print Apr 6.Google Scholar